• Libraries
    • Log in to:
    View Item 
    •   MSpace Home
    • Faculty of Graduate Studies (Electronic Theses and Practica)
    • FGS - Electronic Theses and Practica
    • View Item
    •   MSpace Home
    • Faculty of Graduate Studies (Electronic Theses and Practica)
    • FGS - Electronic Theses and Practica
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    LAG3 expression profile and the mechanisms regulating LAG3 expression and function

    Thumbnail
    View/Open
    Final Thesis (3.473Mb)
    Date
    2021
    Author
    Graydon, Colin Geoffrey
    Metadata
    Show full item record
    Abstract
    During persistent activation of immune cells, immune checkpoints are upregulated and inhibit the cell function. While potentially desirable for autoimmunity and excessive immune activation, immune checkpoints are harmful during cancer and potentially harmful during infection. Immune checkpoint inhibitors have revolutionized the treatment of several forms of cancer. Lymphocyte activation gene-3 (LAG3) is among the most promising immune checkpoints for targeting in cancer due to its efficacy and selective expression. However, much about LAG3 remains unknown. The goal of this thesis was to provide a greater understanding of LAG3 expression and mechanism of action. Because LAG3 research is typically focused on T cells, LAG3 is consequently often ignored on other cells. Also, the LAG3 mechanism of action is mostly uncharacterized due in part to the lack of conserved inhibitory motifs and a consistent model of study. This thesis found that a high frequency of monocytes express LAG3. This expression was confirmed by two separate and frequently used antibodies for LAG3 detection. However, these antibodies detected significantly different fractions of cells expressing LAG3. These antibodies were then tested on LAG3-negative or LAG3-positive Jurkat cells where it was shown that the polyclonal antibody bound non-specifically and with less sensitivity than the monoclonal antibody. Next, LAG3 expression on T cells was shown to be downregulated when cells were activated in the presence of toll-like receptor (TLR) agonists. Suggesting a mechanism of downregulating LAG3 when an infection is active. To study the LAG3 mechanism, a model of LAG3 activity was created using transduced Jurkat cells. This model reflected LAG3-mediated inhibition of IL-2 after activation with superantigen. This model was used to identify MAPK pathway as a branch of the TCR signaling pathway influenced by LAG3 expression. This study sheds light on LAG3 expression and mechanisms of LAG3 expression and function, helping to inform further research into LAG3.
    URI
    http://hdl.handle.net/1993/36115
    Collections
    • FGS - Electronic Theses and Practica [25522]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of MSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV